Lilly Asia backs KSQ Therapeutics, portfolio firm Gritstone raises $100m in IPO

Lilly Asia backs KSQ Therapeutics, portfolio firm Gritstone raises $100m in IPO

Laboratory equipment. Photo: Pixabay

Mars W. Mosqueda Jr.

01 October, 2018

Gritstone OncologyKSQ TherapeuticsLilly Asia Ventures

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2026 All rights reserved.